Study of ocular candidiasis during nine-year period

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Hiroki TanakaHideaki Kawakami

Abstract

To determine the clinical features, fungal profiles, treatment outcomes, and factors that are significantly associated with the visual outcomes of eyes with endogenous fungal endophthalmitis (EFE). The medical records of 17 eyes of 9 patients diagnosed with EFE during January 2005 to December 2013 were reviewed. The collected data included patient characteristics, visual acuities (VAs), length between appearance of the first sign of infection and the first ophthalmic examinations, fungal profiles, and treatment regimen. The main outcome measure was the VA. Statistical analyses were done to detect the factors significantly associated with the visual prognosis. The median age at presentation was 67 years. Seven patients had Candida albicans, and 2 had Candida tropicalis. Eight patients received intravenous fosfluconazole, 4 systemic micafungin, 4 oral itraconazole, and 2 intravenous voriconazole. The minimum inhibitory concentrations of fluconazole against Candida albicans isolated from 5 patients ranged from 0.25 to 1.0 μg/mL. A final VA of ≥20/200 was achieved in 69.2% of the eyes. Multiple regression analysis (r(2) = 0.695) detected both initial logMAR (the Logarithm of the minimum angle of resolution) VA (P = 0.0067) and long...Continue Reading

References

Jul 1, 1982·Ophthalmology·D W ParkeL O Gentry
Feb 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan C SarriaAna M Vidal
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G M GauthierD Andes
Dec 7, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Hiroshi TakebayashiMinoru Tanaka
Jul 20, 2006·Journal of Medical Microbiology·Mohammed A Al-Fattani, L Julia Douglas
Nov 23, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·David GoldblumStefan Zimmerli
Nov 29, 2007·Pharmacotherapy·Fida A KhanRashida A Khakoo
Mar 29, 2008·The British Journal of Ophthalmology·C P ShahJ Maguire
Jun 26, 2008·The British Journal of Ophthalmology·S M HariprasadJ R Graybill
Aug 18, 2009·The Journal of Antimicrobial Chemotherapy·Isabel SprietLudo Willems
Jan 7, 2011·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Koichiro YoshidaYoshihito Niki
Jan 18, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James RiddellCarol A Kauffman
Jul 19, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Astrid M L Oude LashofBart Jan Kullberg
Apr 17, 2012·Diagnostic Microbiology and Infectious Disease·Miki NagaoSatoshi Ichiyama
May 22, 2013·Antimicrobial Agents and Chemotherapy·Kiyofumi MochizukiSatoshi Kishino

❮ Previous
Next ❯

Citations

Jun 15, 2021·Journal of Ophthalmic Inflammation and Infection·Daiki SakaiMakoto Nakamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.